Form 4 for EOG EOG Resources
Accepted 2026-03-16 00:00:00 ET · period of report 2026-03-12 · accession 0000821189-26-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-16 | 2026-03-12 | EOG | Janssen Ann D. | EVP, CFO | D - Sale to Iss | $134.35 | -5,234 | 102.4K | -5% | -$703.2K |
| DM | 2026-03-16 | 2026-03-12 | EOG | Janssen Ann D. | EVP, CFO | M - OptEx | $75.09 | +9,365 | 105.2K | +10% | +$703.2K |
| DM | 2026-03-16 | 2026-03-12 | EOG | Janssen Ann D. | EVP, CFO | S - Sale+OE | $134.32 | -2,597 | 100.2K | -3% | -$348.8K |
| DM | 2026-03-16 | 2026-03-12 | EOG | Janssen Ann D. | EVP, CFO | F - Tax | $134.40 | -1,534 | 101.4K | -1% | -$206.2K |
| DM | 2026-03-16 | 2026-03-12 | EOG | Janssen Ann D. | EVP, CFO | M - OptEx | $0.00 | -9,365 | 5,000 | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-12 | D | D | 2,427 | $135.04 | 102,184.38 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-12 | M | A | 4,365 | $75.09 | 104,611.38 | D | — | — | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. |
| 3 | Common | Common Stock | 2026-03-12 | S | D | 1,422 | $133.76 | 100,246.38 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-12 | F | D | 771 | $133.76 | 101,668.38 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-12 | D | D | 2,807 | $133.76 | 102,439.38 | D | — | — | |
| 6 | Common | Common Stock | 2026-03-12 | M | A | 5,000 | $75.09 | 105,246.38 | D | — | — | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. |
| 7 | Common | Common Stock | 2026-03-12 | F | D | 763 | $135.04 | 101,421.38 | D | — | — | |
| 8 | Common | Common Stock | 2026-03-12 | S | D | 1,175 | $134.99 | 100,246.38 | D | — | — | |
| 9 | Derivative | Stock Appreciation Rights | 2026-03-12 | M | D | 5,000 | $0.00 | 0 | D | $75.09 · 2020-09-26 to 2026-09-26 | 5,000 Common Stock | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. |
| 10 | Derivative | Stock Appreciation Rights | 2026-03-12 | M | D | 4,365 | $0.00 | 5,000 | D | $75.09 · 2020-09-26 to 2026-09-26 | 4,365 Common Stock | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. |